Andrew Adams

Andrew Adams

General Partner



T (203) 717-1370



Andrew Adams,
General Partner

Andrew is a General Partner of Oak HC/FT where he focuses on growth equity and early-stage venture opportunities in healthcare information services.

Andrew currently serves on the Boards of LDI, Limeade, Maestro Health, One Medical Group, US HealthVest and xG Health Solutions. Andrew is also actively involved with Independent Living Systems and Precision for Medicine Holdings.

Prior investment activity includes American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), CLARiENT (acquired by GE Healthcare), Core Informatics (acquired by Thermo Fisher Scientific), Health Dialog (acquired by British United Provident Association), iHealth Technologies (merged with Connolly), NetSpend Corporation (acquired by TSYS), PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by Clayton, Dubilier & Rice) and United BioSource (acquired by Medco Health Solutions).

Prior to joining Oak Investment Partners, Andrew was a Senior Associate with Capital Resource Partners where he focused on investments in healthcare and business services companies. Andrew was also a Financial Analyst in the media and communications group of Deutsche Banc Alex. Brown.

Andrew graduated from Princeton University with a BA in History.